Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The actin protein pseudogene (ENSG00000217495) is classified as a pseudogene, which means it shares sequence similarity to the functional actin genes but is not translated into a functional protein. Actin pseudogenes often arise from duplication or retrotransposition events and usually lack protein-coding capability due to mutations or incomplete gene structure. While functional actin proteins play critical roles in cytoskeletal dynamics, cell motility, and other processes, this pseudogene does not have a direct biological function and is not associated with disease, drug targeting, or therapeutic intervention[1][3][4]. Summary: ENSG00000217495 (Actin protein pseudogene) is not a canonical therapeutic target, encodes no functional protein, and does not participate in classical receptor/enzymatic functions. It is best annotated as a pseudogene, with descriptions and classification reflecting non-coding status and lack of relevance as a drug target[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin protein pseudogene.